Anastasis Nikolaou, 10% Owner at Acrivon Therapeutics, Inc. (ACRV), sold 2,056 shares at $12.14 ($25K) on 2023-06-15, disclosed to the SEC on 2023-06-20.
Open-market sale of $25k ACRV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.